Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_assertion type Assertion NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_head.
- NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_assertion description "[Therefore, SHIP2 remains a significant therapeutic target for the treatment of both obesity and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_provenance.
- NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_assertion evidence source_evidence_literature NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_provenance.
- NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_assertion SIO_000772 15964236 NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_provenance.
- NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_assertion wasDerivedFrom befree-20140225 NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_provenance.
- NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_assertion wasGeneratedBy ECO_0000203 NP611562.RAVWwdnRgRnfrltfcCnA__AliegxvU4J7lWGuwkcZ1Ox0130_provenance.